Financière de Tubize SA (TUB.BR)

EUR 138.8

(-0.86%)

Gross Profit Summary of Financière de Tubize SA

  • Financière de Tubize SA's latest annual gross profit in 2023 was -2.02 Million EUR , down -11.52% from previous year.
  • Financière de Tubize SA's latest quarterly gross profit in 2024 Q2 was -858.02 Thousand EUR , down 0.0% from previous quarter.
  • Financière de Tubize SA reported a annual gross profit of -1.81 Million EUR in annual gross profit 2022, down -21.57% from previous year.
  • Financière de Tubize SA reported a annual gross profit of -1.49 Million EUR in annual gross profit 2021, down 0.0% from previous year.
  • Financière de Tubize SA reported a quarterly gross profit of 900.65 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • Financière de Tubize SA reported a quarterly gross profit of 107.86 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual Gross Profit of Financière de Tubize SA (2023 - 2003)

Year Gross Profit Gross Profit Growth
2023 -2.02 Million EUR -11.52%
2022 -1.81 Million EUR -21.57%
2021 -1.49 Million EUR 0.0%
2020 - EUR -100.0%
2019 4000.00 EUR 0.0%
2018 - EUR 0.0%
2017 - EUR -100.0%
2016 302 Thousand EUR 30100.0%
2015 1000.00 EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%
2010 - EUR 0.0%
2009 - EUR 0.0%
2008 - EUR 0.0%
2007 - EUR 0.0%
2006 - EUR 0.0%
2005 - EUR -100.0%
2004 2000.00 EUR 0.0%
2003 - EUR 0.0%

Peer Gross Profit Comparison of Financière de Tubize SA

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR 428.412%
ABIVAX Société Anonyme 3.91 Million EUR 151.854%
Adocia SA 1.38 Million EUR 246.54%
Aelis Farma SA 12.35 Million EUR 116.423%
Biophytis S.A. -803 Thousand EUR -152.75%
Advicenne S.A. 1.42 Million EUR 242.327%
genOway Société anonyme 20.1 Million EUR 110.097%
IntegraGen SA 5.01 Million EUR 140.444%
Medesis Pharma S.A. -2.66 Million EUR 23.836%
Neovacs S.A. 29.31 Thousand EUR 7023.603%
NFL Biosciences SA -56.06 Thousand EUR -3520.122%
Plant Advanced Technologies SA 2.15 Million EUR 194.271%
Quantum Genomics Société Anonyme -1.41 Million EUR -43.0%
Sensorion SA 3.78 Million EUR 153.581%
Theranexus Société Anonyme -4.63 Million EUR 56.247%
TME Pharma N.V. -127 Thousand EUR -1498.098%
Valbiotis SA 2.66 Million EUR 176.071%
TheraVet SA -530.79 Thousand EUR -282.366%
Valerio Therapeutics Société anonyme 1.26 Million EUR 260.188%
argenx SE 925.49 Million EUR 100.219%
BioSenic S.A. 543 Thousand EUR 473.773%
Celyad Oncology SA 33 Thousand EUR 6250.258%
DBV Technologies S.A. 4.15 Million EUR 148.793%
Galapagos NV 203.73 Million EUR 100.996%
Genfit S.A. 28.22 Million EUR 107.191%
GeNeuro SA -293.8 Thousand EUR -590.805%
Hyloris Pharmaceuticals SA 1.99 Million EUR 201.785%
Innate Pharma S.A. -4.12 Million EUR 50.75%
Inventiva S.A. 17.5 Million EUR 111.598%
MaaT Pharma SA 1.65 Million EUR 222.634%
MedinCell S.A. 9.28 Million EUR 121.852%
Nanobiotix S.A. 36.2 Million EUR 105.605%
Onward Medical N.V. -14.81 Million EUR 86.303%
Oryzon Genomics S.A. 13.94 Million EUR 114.551%
OSE Immunotherapeutics SA 2.22 Million EUR 191.135%
Oxurion NV 104 Thousand EUR 2051.524%
Pharming Group N.V. 220.1 Million EUR 100.922%
Poxel S.A. 1000.00 EUR 203058.5%
GenSight Biologics S.A. 3 Million EUR 167.653%
Transgene SA -28.4 Million EUR 92.855%
UCB SA 3.34 Billion EUR 100.061%
Valneva SE 52.83 Million EUR 103.841%
Vivoryon Therapeutics N.V. -3.09 Million EUR 34.424%